Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

White Paper: Safety Profile of the Analgesic Trezix™ Capsules, Containing the Mild Opioid Dihydrocodeine

Privately held pharmaceutical company Wraser Pharmaceuticals announced the publication of a White Paper addressing opioid safety.

Read More »

The Brink of the Biosimilar Revolution

Although biosimilars have not had the immediate uptake in the United States that they have had in Europe, health plans expect these products will become a staple of therapy for some diseases by 2020 – if the price is right.

Read More »

New White Paper Helps Ambulatory Surgical Centers Understand the Ins and Outs of ASC Marketing

  The white paper from moddern marketing provides five core principles to help ASC owners and investors understand marketing and healthcare consumers.   NEW YORK (PRWEB) February 11, 2019 moddern marketing (moddern), an award-winning independently-owned integrated marketing agency, has released a White Paper for ambulatory surgical center (ASC) owners and investors entitled “Building a Thriving […]

Read More »

Payer Response to Medicare Rebate Policy Changes

A white paper by Health Strategies Group, an Eversana company, which is the leading independent provider of global services to the life sciences industry.

Read More »

Opposites attract: Blurring the lines between small and large molecule manufacturing

This whitepaper assesses the current state of the large molecule sector, and how it may be able to learn from the small molecule industry in terms of its supply chain support infrastructure, as well as its acquisition of staff and the adoption of PAT.

Read More »

Tipping Points of Employer-Sponsored Health Insurance

The American Health Policy Institute (AHPI) released “’Tipping Points’ of Employer-Sponsored Health Insurance,” which examines various factors that could impact broad-based employer-provided health coverage.

Read More »

The Science Behind Biosimilars – Entering a New Era of Biologic Therapy

The American College of Rheumatology published a new white paper, “The Science Behind Biosimilars – Entering a New Era of Biologic Therapy,” providing a comprehensive overview of the scientific, clinical, economic and prescribing issues pertaining to biosimilar use, including efficacy, competition and drug pricing.

Read More »

“Not All Amyloid Beta Therapeutics Are Created Equal”

ProMIS Neurosciences Inc., a biotechnology company focused on the discovery and development of precision treatments for neurodegenerative diseases, announced it has issued a new scientific white paper entitled: ‘Not all Amyloid Beta Therapeutics are Created Equal’.

Read More »

Personalized Medicine and Value Assessment Frameworks: Context, Considerations, and Next Steps

In this white paper, PMC contends that most value assessment frameworks could unintentionally undermine the health care community’s push toward more personalized care.

Read More »

2017 U.S. Trends in Aggregate Spend, Disclosure and Transparency

With the focus shifting away from the end reporting, companies have continued to invest in systems and processes that manage “upstream” relationships with healthcare providers and consultants, recognizing that the greater compliance risks center around these relationships than on the reported spend itself.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

April 2019 Focus: Healthcare agency & network profiles, industry overview & awards, and more!

Subscribe

Ad Right Bottom